Identification of Circulating Endocan-1 and Ether Phospholipids as Biomarkers for Complications in Thalassemia Patients

Despite advances in our knowledge and attempts to improve therapies, β-thalassemia remains a prevalent disorder with increased risk for the development of cardiomyopathy. Using an untargeted discovery-based lipidomic workflow, we uncovered that transfusion-dependent thalassemia (TDT) patients had a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Metabolites
Autors principals: Botta, Amy, Forest, Anik, Daneault, Caroline, Pantopoulos, Kostas, Tantiworawit, Adisak, Phrommintikul, Arintaya, Chattipakorn, Siriporn, Chattipakorn, Nipon, Des Rosiers, Christine, Sweeney, Gary
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7912378/
https://ncbi.nlm.nih.gov/pubmed/33530524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/metabo11020070
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars